Company completes first tranche of a $7 million financing to increase cash runway and maintain Nasdaq complianceSOUTH SAN FRANCISCO, Calif., Oct.
HanchorBio today announced that its proprietary HCB101, a SIRPa/CD47 fusion protein candidate, has been officially granted a US patent (Patent No.
HanchorBio today announced that its proprietary HCB101, a SIRPα/CD47 fusion protein candidate, has been officially granted a US patent (Patent No. 12,447,195) by the United States Patent and Trademark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback